Updates are available Correction dated 2021-06-24
Click to view Correction: https://doi.org/10.1186/s12879-021-06330-1
-
Authors
Merlini, Esther
Cozzi-lepri, Alessandro
Castagna, Antonella
Costantini, Andrea
Caputo, Sergio Lo
Carrara, Stefania
Quiros-Roldan, Eugenia
Ursitti, Maria A.
Antinori, Andrea
D’Arminio Monforte, Antonella
Marchetti, Giulia
- License Information
-
More Information
Article History
Received: 22 January 2021
Accepted: 28 May 2021
First Online: 12 June 2021
Change Date: 24 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12879-021-06330-1
Declarations
:
: The Icona Foundation study was approved by the Ethics Committee (Institutional Review Board) of each participating institution. In particular, the Ethical approval was obtained by the following IRB: UnorderedList removedAll of the individuals enrolled provided a written informed consent at the time of the enrolment or, if subjects are under 18, from a parent and/or legal guardian. Likewise, in case of dead, informed consent for study participation was obtained by parent and/or legal guardian. All procedures of the study were performed in accordance with the 1964 The Declaration of Helsinki and its later amendments.
: Not applicable.
: EM, ACL, ACa, ACo, SLC, SC, EQR and MAU have nothing to disclose. AA outside the submitted work reports grants, personal fees and non-financial support from Gilead Sciences, ViiV Healthcare and Bristol Myers Squibb, grants and personal fees from Janssen-Cilag, personal fees from Merck Sharp and Dohme and personal fees and non-financial support from Abbvie. ADM outside the submitted work reports grants and personal fees from Gilead Sciences, ViiV Healthcare and Merck Sharp and Dohme and personal fees from Janssen and Bristol Myers Squibb. GM outside the submitted work reports personal fees from Gilead Sciences and ViiV Healthcare.
